Share

People

People search

David Wilson

David Wilson

David Wilson

  • Role Partner, intellectual property
  • Office London
  • Email David Wilson
  • Tel +44 20 7466 2179
Download vCard

With a background in science, David is well qualified to advise on technical issues in the life sciences sector and chemical industries. He is viewed as an outstanding practitioner and a leader in his field, specialising in complex patent litigation involving multi-jurisdictional disputes between major science and technology companies.

David is highly commended by major legal directories and successfully represented a client in one of the largest patent litigations ever heard in the United Kingdom. He also advises on trade marks, regulatory and non-contentious contractual, licensing and corporate matters.

With a first-class honours degree in chemistry, David began his career in the chemical and life sciences (immunodiagnostics) industry. He is also qualified as a barrister. In addition to his legal work, David was a consulting editor of International Patent Litigation: Developing an Effective Strategy, an acclaimed practical guide to patent litigation.

Experience

  • Daiichi in defence of a UK patent revocation for one of the world’s leading antibiotic drugs brought by Generics (UK) Ltd, which resulted in a three-week trial
  • Abbott Laboratories in a high-value action brought by GlaxoSmithKline (GSK) under two GSK patent licences involving several patent families
  • Pfizer Inc. on the patent revocation action brought by biotech Lilly ICOS against Pfizer’s field of use patent for sildenafil (Viagra)
  • Transkaryotic Therapies (TKT) and Hoechst Marion Roussel (HMR is now part of Sanofi-Aventis) in proceedings against US multinational biopharmaceutical Amgen over TKT’s ‘gene-activated’ erythropoietin product
  • Celltech Group plc in its long-running dispute against MedImmune over the non-payment of patent licence royalties, with three consecutive sets of proceedings in the High Court of England and Wales  involving questions of US patent law and German patent law